Clienia Privatklinik Schlössli
Oetwil am See, Switzerland
Treatment & access
- Treatments offeredEsketamine nasal spray (Spravato®)
- Access routeCovered by a national programme
- Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
- ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
- Phone+41 44 929 81 11
- Websitehttps://www.clienia.ch/de/standorte/clienia-schloessli/
Related listings
These records belong to the same organisation. They are listed separately because each is a distinct programme or location.
- Location in LittenheidClienia Privatklink Littenheid : Spravato®
- Location in FreidorfJacqueline Binswanger : PAT
About this provider
Clienia Privatklinik Schlössli in Oetwil am See (canton Zurich), founded in 1889, is one of the largest psychiatric clinics in Switzerland and part of the Clienia group. It provides acute inpatient psychiatry and psychotherapy for adults, older adults and young people, combining basic-care wards with supra-regional specialised units, and its admission and emergency service is staffed around the clock. The Clienia group describes a structured (es)ketamine treatment program, including the Spravato nasal spray approved in Switzerland for treatment-resistant depression, supervised by physicians and specially trained nursing staff.
Services & programs
- Esketamine (Spravato) nasal-spray treatment for treatment-resistant depression (physician-supervised, usually outpatient)
- Acute inpatient psychiatry and psychotherapy for adults, seniors and young people
Common questions
How do I access esketamine (Spravato) treatment here?
Access runs through a psychiatrist. Your treating psychiatrist assesses whether you meet the Swiss criteria for treatment-resistant depression and refers you; before treatment a detailed consultation takes place and your consent is obtained.
Is the treatment covered by health insurance?
Spravato is reimbursed by Swiss mandatory health insurance for treatment-resistant depression within the official criteria; the insurer's cost approval (Kostengutsprache) must be in place before the first dose.
What does a treatment session involve?
The Clienia group describes a preparation phase, self-administration of the nasal spray under a physician's guidance, around 90 minutes of monitoring on site and a concluding consultation - about two and a half hours in total, mostly on an outpatient basis.
55 more verified providers within 50 km
- Stäfa · 3 kmTruls Bär : PAT
- Meilen · 6 kmPrivatklinik Hohenegg, Meilen : Spravato®
- Meilen · 6 kmMarco Ackermann : PAT
Practical details
As stated on the provider's own website (checked 2026-09-09); details can change — confirm when you book.
- Opening hoursEmpfang: Mo–Fr 07:00–20:00, Sa/So/Feiertage 09:00–20:00; Aufnahme-/Notfalldienst rund um die Uhr Source →
Verification
- License / registryBAG SL Limitatio
- Official registryhttps://www.bag.admin.ch/dam/de/sd-web/uo93E02fcJBh/Liste%20der%20Zentren%20gem%C3%A4ss%20der%20Limitierung%20von%20Spravato_20251001.pdf
- Last verified
Check your fit & enquire
Spravato® access in Switzerland follows published criteria. A short pre-screening comes first, then your compiled summary goes to Clienia Privatklinik Schlössli only with your explicit consent, and you can download it for yourself either way.
Why enquire via PsyAccess
- Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
- A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
- Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.